Mr. Bruce Goodwin is the Joint Project Lead (JPL) for Chemical, Biological, Radiological and Nuclear Defense (CBRND) Enabling Biotechnologies (EB). He assumed his duties as JPL in April 2020, and he reports directly to the Joint Program Executive Officer for CBRND.
As the JPL CBRND EB, Mr. Goodwin is responsible for leading EB’s mission to provide a resilient, rapid, operationally relevant Chem Bio Defense response capability that enables our warfighter to fight and win in a CBRN-contested environment. Mr. Goodwin is committed to finding innovative approaches across the medical countermeasure (MCM) development spectrum by building, maturing, mitigating risk, and integrating relevant capabilities and infrastructure to support accelerated MCM development, manufacturing, testing, and deployment.
Prior to his current assignment, Mr. Goodwin has held numerous positions at the JPEO-CBRND including Science Manager, Deputy Program Director Critical Reagents Program, Acting Deputy Joint Project Manager for Biosurveillance, Program Director Critical Reagents Program/Defense Biologic Product Assurance Office (DBPAO), and Chief Operating Officer JPL CBRND EB. He spent an additional 15+ years in private industry (manufacturing) in positions ranging from Production Technician at Chesapeake Biological Laboratories to Laboratory Manager at MRI Global.
Mr. Goodwin earned a B.S. in Biology from Salisbury University, is a Practitioner-level certified in Program Management from the Defense Acquisition University and is also a member of the U.S. Army Civilian Critical Acquisition Workforce.